What is methylene blue an antidote for?
METHYLENE BLUE AS ANTIDOTE FOR CYANIDE AND CARBON MONOXIDE POISONING.
How do you neutralize methylene blue?
When a solution of potassium hydroxide, dextrose and methylene blue is shaken, the oxygen dissolves into the colorless solution causing the methylene blue to oxidize into its blue form. As the blue solution is left to stand, the solution turns colorless as the methylene blue is reduced.
How do you give methylene blue IV?
Administer PROVAYBLUE® 1 mg/kg intravenously over 5-30 minutes. If the methemoglobin level remains greater than 30% or if clinical signs and symptoms persist, a repeat dose of PROVAYBLUE® 1 mg/kg may be given one hour after the first dose.
How is methemoglobinemia treated?
Methylene blue is used to treat severe cases of MetHb, and doctors may prescribe ascorbic acid to reduce the level of methemoglobin in the blood. In severe cases, a person may require a blood transfusion or exchange transfusion. Oxygen therapy will also be provided, if required.
What is the antidote of atropine?
The antidote to atropine is physostigmine or pilocarpine.
Does glucose reduce methylene blue?
An alkaline solution of glucose acts as a reducing agent and reduces added methylene blue from a blue to a colourless form. When the dissolved oxygen has been consumed, the methylene blue is slowly reduced back to its colourless form by the remaining glucose, and the cycle can be repeated many times by further shaking.
What is the chemical formula for methylene blue?
C16H18ClN3S
Methylene blue/Formula
When do you give methylene blue for methemoglobinemia?
Those with high risk comorbidities (anemia, CHF, pneumonia, angina) may require methylene blue at lower methemoglobin levels. Dosing for methylene blue is 1-2 mg/kg (0.1 to 0.2 mL/kg) of a 1% solution admin- istered intravenously over five minutes.
How do you reverse methemoglobinemia?
Methylene Blue is the standard first-line antidote for methemoglobinemia. The drug acts as a cofactor for NADPH reductase and ultimately increases the rate of conversion of ferric methemoglobin to ferrous hemoglobin.